NDC 67877-0577-30
Minocycline Hydrochloride 135 mg/1 TABLET, FILM COATED, EXTENDED RELEASE
Available — 2-Day Shipping
NDC
67877-0577-30
Generic Name
Minocycline Hydrochloride
Brand Name
Minocycline Hydrochloride
Strength
135 mg/1
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Package Size
—
Labeler
Ascend Laboratories, LLC
FDA Drug Information
Indications & Usage
1 INDICATIONS & USAGE Minocycline hydrochloride extended-release tablets is indicated to treat inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients 12 years of age and older. Limitations of Use Minocycline hydrochloride extended-release tablets did not demonstrate any effect on non-inflammatory acne lesions. This formulation of minocycline has not been evaluated in the treatment of infections [see Clinical Studies ( 14 )]. To reduce the development of drug-resistant b…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Minocycline Hydrochloride Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Other Minocycline Hydrochloride NDC Codes
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 67877-0577-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).